Literature DB >> 10619544

Focusing versus distraction and the response to clinical electric shocks.

P C Duker1, J van den Bercken, M A Foekens.   

Abstract

This study pertains to assessing the effects of electric shocks that are used in the treatment of severe self-injurious behavior. With pain sensation and startle response as the dependent variables and focusing versus distraction of recipient's attention to the electric shocks as the independent variable, these stimuli were administered to 60 paid volunteers. Using ANOVA, no significant effect of the independent variable was found on either measure. However, repeated administration of the electric shock produced a significant increment of pain sensation, with a concomitant significant decrease of magnitude of the startle response. No interaction effect was found.

Entities:  

Mesh:

Year:  1999        PMID: 10619544     DOI: 10.1016/s0005-7916(99)00025-7

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  4 in total

1.  Assessing Non-Suicidal Self-Injury in the Laboratory.

Authors:  Brooke A Ammerman; Mitchell E Berman; Michael S McCloskey
Journal:  Arch Suicide Res       Date:  2017-06-05

2.  Video-Based Analysis of Bodily Startle and Subsequent Emotional Facial Expression in Posttraumatic Stress Disorder.

Authors:  Jens Blechert; Tanja Michael; Frank H Wilhelm
Journal:  J Exp Psychopathol       Date:  2019-05-21

3.  Are Cognitive Load and Focus of Attention Differentially Involved in Pain Management: An Experimental Study Using a Cold Pressor Test and Virtual Reality.

Authors:  Stéphanie Dumoulin; Stéphane Bouchard; Claudie Loranger; Pamela Quintana; Véronique Gougeon; Kim L Lavoie
Journal:  J Pain Res       Date:  2020-09-04       Impact factor: 3.133

4.  An incremental dual-task paradigm to investigate pain attenuation by task difficulty, affective content and threat value.

Authors:  Quoc C Vuong; Angela Owen; Kehinde Akin-Akinyosoye; Vera Araujo-Soares
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.